Help
RSS
API
Feed
Maltego
Contact
Domain > www.gilenya.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2024-04-20
45.60.121.251
(
ClassC
)
2025-03-25
45.60.11.232
(
ClassC
)
Port 80
HTTP/1.1 200 OKDate: Sat, 20 Apr 2024 12:44:35 GMTServer: WSX-Frame-Options: SAMEORIGINX-XSS-Protection: 1; modeblockX-Content-Type-Options: nosniffContent-Type: text/htmlX-Powered-By: JSP/2.3Set-Cook !DOCTYPE html>html langen>head>title>Relapsing-Remitting Multiple Sclerosis I GILENYA/title>meta content namesearchTitle>meta contentLearn about GILENYA® (fingolimod), a once-daily oral pill used to treat RRMS and find out more about its generic versions. See full prescribing & safety info. nameDESCRIPTION>meta contentrrms treatment, ms pill, relapsing multiple sclerosis, relapsing-remitting multiple sclerosis treatment, multiple sclerosis, Gilenya nameKEYWORDS>meta content nameHEADER>meta contentNOODP,NOYDIR namerobots>meta nameviewport contentwidthdevice-width, initial-scale1.0, minimum-scale1, maximum-scale1.0, user-scalableno />meta charsetUTF-8 http-equivX-UA-Compatible contentIEedge,chrome1 />meta http-equivCache-Control contentno-cache, no-store, must-revalidate />meta http-equivPragma contentno-cache />meta http-equivExpires content0 />meta nameformat-detection contenttelephoneno>meta namefacebook-domain-verification contentk4tvtlxpakt44w5qrgh48cnkgoiuho />!-- dataLaterPharma Parameters -->script typetext/javascript>window.dataLayerPharma window.dataLayerPharma || ;var level1 level1 || ;var level2 level2 || ;var statusCode statusCode || ;var status (typeof(statusCode) undefined || (statusCode0)) ? 200 : statusCode;var currName ((typeof(level1) undefined || (level10)) ? : ( - + level1) );currName ((typeof(level2) undefined || (level20)) ? currName : (currName + - + level2) );dataLayerPharma.push({ page: { environment: staging, department: pharma, indication: , brand: gilenya, hcpVsPatient: patient, sectionLevel1: level1, sectionLevel2: level2, sectionLevel3: , name: hcp - gilenya + currName, status: status } });/script>!-- End dataLaterPharma Parameters -->!-- Meta Pixel Code -->script>!function(f,b,e,v,n,t,s){if(f.fbq)return;nf.fbqfunction(){n.callMethod?n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbqn;n.pushn;n.loaded!0;n.version2.0;n.queue;tb.createElement(e);t.async!0;t.srcv;sb.getElementsByTagNa
Port 443
HTTP/1.1 200 OKDate: Sat, 20 Apr 2024 12:44:36 GMTServer: WSX-Frame-Options: SAMEORIGINX-XSS-Protection: 1; modeblockX-Content-Type-Options: nosniffContent-Type: text/htmlStrict-Transport-Security: ma !DOCTYPE html>html langen>head>title>Relapsing-Remitting Multiple Sclerosis I GILENYA/title>meta content namesearchTitle>meta contentLearn about GILENYA® (fingolimod), a once-daily oral pill used to treat RRMS and find out more about its generic versions. See full prescribing & safety info. nameDESCRIPTION>meta contentrrms treatment, ms pill, relapsing multiple sclerosis, relapsing-remitting multiple sclerosis treatment, multiple sclerosis, Gilenya nameKEYWORDS>meta content nameHEADER>meta contentNOODP,NOYDIR namerobots>meta nameviewport contentwidthdevice-width, initial-scale1.0, minimum-scale1, maximum-scale1.0, user-scalableno />meta charsetUTF-8 http-equivX-UA-Compatible contentIEedge,chrome1 />meta http-equivCache-Control contentno-cache, no-store, must-revalidate />meta http-equivPragma contentno-cache />meta http-equivExpires content0 />meta nameformat-detection contenttelephoneno>meta namefacebook-domain-verification contentk4tvtlxpakt44w5qrgh48cnkgoiuho />!-- dataLaterPharma Parameters -->script typetext/javascript>window.dataLayerPharma window.dataLayerPharma || ;var level1 level1 || ;var level2 level2 || ;var statusCode statusCode || ;var status (typeof(statusCode) undefined || (statusCode0)) ? 200 : statusCode;var currName ((typeof(level1) undefined || (level10)) ? : ( - + level1) );currName ((typeof(level2) undefined || (level20)) ? currName : (currName + - + level2) );dataLayerPharma.push({ page: { environment: staging, department: pharma, indication: , brand: gilenya, hcpVsPatient: patient, sectionLevel1: level1, sectionLevel2: level2, sectionLevel3: , name: hcp - gilenya + currName, status: status } });/script>!-- End dataLaterPharma Parameters -->!-- Meta Pixel Code -->script>!function(f,b,e,v,n,t,s){if(f.fbq)return;nf.fbqfunction(){n.callMethod?n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbqn;n.pushn;n.loaded!0;n.version2.0;n.queue;tb.createElement(e);t.async!0;t.srcv;sb.getElementsByTagNa
Subdomains
Date
Domain
IP
supportqa.gilenya.com
2025-03-15
45.60.73.181
support.gilenya.com
2025-01-17
107.154.109.156
www.gilenya.com
2024-04-20
45.60.121.251
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]